DiaMedica Therapeutics (DMAC) Other Working Capital Changes: 2017-2024
Historic Other Working Capital Changes for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to -$184,000.
- DiaMedica Therapeutics' Other Working Capital Changes fell 120.10% to -$42,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$322,000, marking a year-over-year decrease of 204.55%. This contributed to the annual value of -$184,000 for FY2024, which is 215.00% down from last year.
- Per DiaMedica Therapeutics' latest filing, its Other Working Capital Changes stood at -$184,000 for FY2024, which was down 215.00% from $160,000 recorded in FY2023.
- DiaMedica Therapeutics' Other Working Capital Changes' 5-year high stood at $160,000 during FY2023, with a 5-year trough of -$184,000 in FY2024.
- Its 3-year average for Other Working Capital Changes is $10,000, with a median of $54,000 in 2022.
- As far as peak fluctuations go, DiaMedica Therapeutics' Other Working Capital Changes spiked by 623.53% in 2021, and later plummeted by 215.00% in 2024.
- DiaMedica Therapeutics' Other Working Capital Changes (Yearly) stood at $17,000 in 2020, then soared by 623.53% to $123,000 in 2021, then slumped by 56.10% to $54,000 in 2022, then surged by 196.30% to $160,000 in 2023, then plummeted by 215.00% to -$184,000 in 2024.